#GLP1 #Obesity #Type2Diabetes #ClinicalTrials #MetabolicHealth #DrugDevelopment #ClinicalResearch To view or add a comment, sign in - The European Commission has approved Wegovy (once-daily oral semaglutide 25 mg) for adults living with obesity or overweight with at least one weight-related comorbidity, offering the first GLP-1 receptor agonist in tablet form for weight management across all EU member states
MAGIC (Mayo Anesthesia Gastric Imaging Collaborative) Collaborators
Clinical recommendations suggest that people taking GLP-1 drugs should consume 80 - 120 grams of proteins per day. By focusing on high quality protein source - like lean meats, eggs, dairy, and plant-based proteins like soy - you make sure your body is getting the protein it needs to support musce repair and growth
It's worth noting that GLP-1 isn't a hormone replacement and won't address symptoms like hot flushes or night sweats that are directly caused by oestrogen decline
For some individuals, 5 mg provides sufficient weight loss with minimal side effects, making higher doses unnecessary
Sermorelin is a synthetic version of the naturally occurring growth hormone-releasing hormone (GHRH), a naturally-occuring peptide that tells your pituitary gland to release more growth hormone (2)